company background image
ACT

AlzChem Group XTRA:ACT Stock Report

Last Price

€18.50

Market Cap

€187.5m

7D

-3.6%

1Y

-24.8%

Updated

05 Dec, 2022

Data

Company Financials +
ACT fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends3/6

ACT Stock Overview

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally.

AlzChem Group AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for AlzChem Group
Historical stock prices
Current Share Price€18.50
52 Week High€25.00
52 Week Low€14.80
Beta1.04
1 Month Change13.85%
3 Month Change5.71%
1 Year Change-24.80%
3 Year Change-8.42%
5 Year Change-40.32%
Change since IPO-31.20%

Recent News & Updates

Recent updates

AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year

Apr 24
AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year

AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00

Mar 29
AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00

AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00

Feb 27
AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00

AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Nov 23
AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?

Jun 10
Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?

At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?

Apr 07
At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?

AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?

Mar 23
AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?

AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price

Mar 10
AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price

Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 24
Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)

Feb 11
Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)

Update: AlzChem Group (ETR:ACT) Stock Gained 13% In The Last Year

Aug 07
Update: AlzChem Group (ETR:ACT) Stock Gained 13% In The Last Year

Is Now An Opportune Moment To Examine AlzChem Group AG (ETR:ACT)?

Jul 20
Is Now An Opportune Moment To Examine AlzChem Group AG (ETR:ACT)?

Does This Valuation Of AlzChem Group AG (ETR:ACT) Imply Investors Are Overpaying?

Jul 03
Does This Valuation Of AlzChem Group AG (ETR:ACT) Imply Investors Are Overpaying?

Shareholder Returns

ACTDE ChemicalsDE Market
7D-3.6%-1.9%0.9%
1Y-24.8%-19.3%-16.8%

Return vs Industry: ACT underperformed the German Chemicals industry which returned -16.7% over the past year.

Return vs Market: ACT underperformed the German Market which returned -15.6% over the past year.

Price Volatility

Is ACT's price volatile compared to industry and market?
ACT volatility
ACT Average Weekly Movement4.3%
Chemicals Industry Average Movement5.7%
Market Average Movement5.7%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.5%

Stable Share Price: ACT is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: ACT's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19081,570Andreas Niedermaierhttps://www.alzchem.com

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand.

AlzChem Group AG Fundamentals Summary

How do AlzChem Group's earnings and revenue compare to its market cap?
ACT fundamental statistics
Market Cap€187.51m
Earnings (TTM)€29.07m
Revenue (TTM)€534.32m

6.5x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ACT income statement (TTM)
Revenue€534.32m
Cost of Revenue€253.99m
Gross Profit€280.33m
Other Expenses€251.26m
Earnings€29.07m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 28, 2023

Earnings per share (EPS)2.87
Gross Margin52.46%
Net Profit Margin5.44%
Debt/Equity Ratio0.0%

How did ACT perform over the long term?

See historical performance and comparison

Dividends

5.4%

Current Dividend Yield

35%

Payout Ratio